Identification
- Composition (DCI)
- irbésartan
- Manufacturer
- SANOFI AVENTIS MAROC
- ATC code
- C09CA04
- Presentation
- Boîte de 28
- Schedule / Reimb.
- A
- Hospital price
- 136.30 MAD
Indications
APROVEL® est indiqué chez l’adulte dans le traitement de l’hypertension artérielle essentielle. Il est également indiqué dans le traitement de l’atteinte rénale chez les patients adultes hypertendus diabétiques de type 2, dans le cadre de la prise en charge par un médicament antihypertenseur.
Find an open pharmacy
On-call pharmacies near you
About APROVEL 300 MG
APROVEL 300 MG is marketed in Morocco by SANOFI AVENTIS MAROC and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of APROVEL 300 MG, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about APROVEL 300 MG
Answers to common questions from Moroccan patients about this drug.